Geiseler - Figure 10

Consequences of Mucus Hypersecretion in COPD

References

[1]

Ha EVS, Rogers DF. Novel therapies to inhibit mucus synthesis and secretion in airway hypersecretory diseases. Pharmacology 2016;97:84–100.

[6]

Putcha N, Han MK, Martinez CH, et al. Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans. J COPD F. 2014; 1(1): 105-114.

[7]

Buist AS. The US Lung Health Study. Respirology 1997;2(4):303-307.

[8]

Hartman JE, Prinzen J, van Lummel RC, ten Hacken NHT. Frequent sputum production is associated with disturbed night’s rest an impaired sleep quality in patients with COPD. Sleep Breath 2015;19(4):1125-1133.